Call for Abstract
Scientific Program
12th European Diabetes Congress, will be organized around the theme “New Therapeutic Mechanisms of Diabetes ”
Euro Diabetes 2016 is comprised of 11 tracks and 78 sessions designed to offer comprehensive sessions that address current issues in Euro Diabetes 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1 New Discoveries and Emerging Therapies for Type 1 Diabetes
- Track 1-2New Discovery and Treatment for Type 2 Diabetes
- Track 1-3New Therapeutic Mechanisms for Diabetes
- Track 1-4Other advanced medical technologies used in hospitals
- Track 1-5Exploring novel therapies in diabetes treatment
- Track 2-1Obesity and diabetes
- Track 2-2Diabetic dyslipidemia
- Track 2-3Bioinformatics tools and techniques used in diabetes Research
- Track 2-4Diabesity - Methods to control or prevent diabetes in obese people
- Track 2-5Latent autoimmune diabetes of adults (LADA)
- Track 2-6Symposia on Anti- Inflamatory Strategies in Metabolic Disorders
- Track 3-1Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes
- Track 3-2Diabetes and cancer
- Track 3-3Oral therapies: secretagogues
- Track 3-4Incretin based therapies
- Track 3-5Novel agents in treatment
- Track 3-6Updates of anti-diabetic agents
- Track 3-7Updates of anti-diabetic agents
- Track 3-8Measurement of insulin resistance and secretion in diabetes clinic
- Track 3-9Diabetes Case Reports
- Track 4-1Computational approach to chemical etiologies of diabetes
- Track 4-2Computational disease gene identification
- Track 4-3Model construction processes for survival prediction
- Track 4-4Computational Methods for the Early Detection of Diabetes
- Track 4-5Computational techniques to uncover the etiology of disease
- Track 4-6Innovative Bioinformatic methods for Diabetes
- Track 5-1Mechanisms of Pancreatic β-Cell in Type 1 and Type 2 Diabetes
- Track 5-2Diabetes stem cell
- Track 5-3Cure for Type 1 Diabetes Stem Cells
- Track 5-4Embryonic stem cell therapy for diabetes and its complications
- Track 5-5Beta Cells in Type 1 Diabetes
- Track 6-1Type 1 and Type 2 diabetes -Complications and treatment
- Track 6-2Microvascular complications: Retinopathy, neuropathy, and nephropathy
- Track 6-3Macrovascular complications: Coronary artery diseases, cardiomyopathy, and stroke
- Track 6-4Hypoglycemia, Hyperglycemia and glycosylated hemoglobin
- Track 6-5Latent autoimmune diabetes of adults (LADA)
- Track 6-6Hypertension
- Track 6-7Embryonic stem cell therapy for diabetes and its complications
- Track 6-8Preclinical safety evaluation of stem cell-based therapies for diabetes
- Track 6-9Nephrogenic Diabetes Insipidus
- Track 7-1Genetics of metabolic syndrome: Challenges and relation with diabetes mellitus
- Track 7-2Recent advances in genetics of diabetes
- Track 7-3Diabetes in specific ethnic groups
- Track 7-4Genetic-lifestyle interactions in the development and prevention of diabetes
- Track 7-5Understanding the genetics of diabetes
- Track 8-1Medication options- Anti-seizure medications, Antidepressants, Lidocaine patch & Opioids
- Track 8-2Antiepileptic drugs & Serotonin inhibitors
- Track 8-3Over the counter & prescription medications
- Track 8-4Alternative treatments for diabetic neuropathy
- Track 8-5Diabetic Neuropathy and dietary supplements
- Track 8-6Latest advanced alternative therapies for Diabetes
- Track 9-1Impact of food & nutrition in diabetes management
- Track 9-2Impact of physical activity & yoga therapy
- Track 9-3Personalized Management of Hyperglycemia in Type 2 Diabetes
- Track 9-4Diabetic foot: Care and management
- Track 9-5Standards of Medical Care in Diabetes
- Track 9-6Lifestyle and eating habits relate to diabetes
- Track 9-7Advanced diet products for Diabetes
- Track 9-8Diabetic Meal plan
- Track 9-9Pre-diabetes Diet
- Track 10-1Bolus insulin and Conventional Insulin
- Track 10-2Islet Cell Transplantation for Diabetes
- Track 10-3Xenotransplantation for the Treatment of Type 1 Diabetes
- Track 10-4Pancreas Transplantation
- Track 10-5Clinical Trial on Islet Transplants
- Track 10-6New insights into beta cell signaling pathways
- Track 10-7The role of non-beta cells in glucose homeostasis
- Track 10-8Novel drug targets to preserve and/or promote proliferation of beta cells
- Track 10-9Islet transplants
- Track 10-10Pancreatic islet transplantation
- Track 10-11Xenotransplantation
- Track 10-12Bolus insulin
- Track 10-13Conventional insulinotherapy
- Track 11-1Diagnosis & Treatment of Endocrine disorders
- Track 11-2Current Advances in Endocrinology & Metabolism
- Track 11-3Paediatric Endocrinology Disorders & Treatment
- Track 11-4General Endocrinology
- Track 11-5Clinical Trials in Endocrinology